A photo of Kelli Dominick.

Psychiatrist, Division of Child and Adolescent Psychiatry

Assistant Professor, UC Department of Psychiatry and Behavioral Neuroscience

513-636-4124

Board Certified

My Biography & Research

Biography

Kelli Dominick, MD, PhD, is an assistant professor for the Division of Psychiatry at Cincinnati Children’s Hospital Medical Center who specializes in the clinical care and research in neurodevelopmental disorders including Autism Spectrum Disorder and Fragile X Syndrome. Dr. Dominick received her undergraduate degree in Biology and Psychology at Transylvania University. She then earned her MD and PhD degrees at Boston University School of Medicine where she was awarded a pre-doctoral fellowship (F30 NRSA) from the National Institutes of Health. She completed a combined residency program in pediatrics, adult and child psychiatry at Cincinnati Children’s Hospital Medical Center.

Dr. Dominick’s research interests include the use of neuroimaging to examine neural development, early identification and treatment of autism spectrum disorder and Fragile X Syndrome.

Academic Affiliation

Assistant Professor, UC Department of Psychiatry and Behavioral Neuroscience

Clinical Divisions

Psychiatry

Research Divisions

Psychiatry

My Locations

My Education

MD, PhD: Boston University School of Medicine, Boston, MA, 2011.

Residency: Pediatrics/Adult Psychiatry/Child Psychiatry, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2016.

Certification: Pediatrics, American Board of Pediatrics.

My Publications

Letter to the Editor: Chlorpromazine-Induced Skin Pigmentation in a Pediatric Patient. Harris, K; Lamy, M; Sorter, M; Frye, C; Terhune, L; Erickson, CA; Ruschman, G; Dominick, KC. Journal of Child and Adolescent Psychopharmacology. 2021; 31:516-517.

Sex differences in resting EEG power in Fragile X Syndrome. Smith, EG; Pedapati, EV; Liu, R; Schmitt, LM; Dominick, KC; Shaffer, RC; Sweeney, JA; Erickson, CA. Journal of Psychiatric Research. 2021; 138:89-95.

Brief Report: Intranasal Ketamine in Adolescents and Young Adults with Autism Spectrum Disorder-Initial Results of a Randomized, Controlled, Crossover, Pilot Study. Wink, LK; Reisinger, DL; Horn, P; Shaffer, RC; O'Brien, K; Schmitt, L; Dominick, KR; Pedapati, EV; Erickson, CA. Journal of Autism and Developmental Disorders. 2021; 51:1392-1399.

Developmental studies in fragile X syndrome. Razak, KA; Dominick, KC; Erickson, CA. Journal of Neurodevelopmental Disorders. 2020; 12.

Recent Advances in the Pharmacological Management of Behavioral Disturbances Associated with Autism Spectrum Disorder in Children and Adolescents. Lamy, M; Pedapati, EV; Dominick, KL; Wink, LK; Erickson, CA. Paediatric Drugs. 2020; 22:473-483.

Examination of Correlates to Health-Related Quality of Life in Individuals with Fragile X Syndrome. Coffman, MC; Shaffer, RC; Schmitt, LM; Dominick, KC; Pedapati, E; Wang, A; Berry-Kravis, E; Tartaglia, N; Erickson, CA. Brain Sciences. 2020; 10.

Pediatric Quality of Life Inventory (PedsQL) in Fragile X Syndrome. Fitzpatrick, SE; Schmitt, LM; Adams, R; Pedapati, EV; Wink, LK; Shaffer, RC; Sage, J; Weber, JD; Dominick, KC; Erickson, CA. Journal of Autism and Developmental Disorders. 2020; 50:1056-1063.

Atypical Social Attention and Emotional Face Processing in Autism Spectrum Disorder: Insights From Face Scanning and Pupillometry. Reisinger, DL; Shaffer, RC; Horn, PS; Hong, MP; Pedapati, EV; Dominick, KC; Erickson, CA. Frontiers in Integrative Neuroscience. 2020; 13.

The Relationship between Expressive Language Sampling and Clinical Measures in Fragile X Syndrome and Typical Development. Shaffer, RC; Schmitt, L; Thurman, AJ; Abbeduto, L; Hong, M; Pedapati, E; Dominick, K; Sweeney, J; Erickson, C. Brain Sciences. 2020; 10.

Differentiating social preference and social anxiety phenotypes in fragile X syndrome using an eye gaze analysis: a pilot study. Hong, MP; Eckert, EM; Pedapati, EV; Shaffer, RC; Dominick, KC; Wink, LK; Sweeney, JA; Erickson, CA. Journal of Neurodevelopmental Disorders. 2019; 11.